115 related articles for article (PubMed ID: 29215949)
1. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
[TBL] [Abstract][Full Text] [Related]
2. Robot-assisted retroperitoneal lymph node dissection: Initial experience in Japan.
Takahara K; Motonaga T; Okumura J; Yamakawa S; Yagi K; Nakamura W; Saruta M; Nukaya T; Takenaka M; Zennami K; Ichino M; Sasaki H; Sumitomo M; Shiroki R
Asian J Endosc Surg; 2024 Jan; 17(1):e13262. PubMed ID: 37944943
[TBL] [Abstract][Full Text] [Related]
3. Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor.
Venishetty N; Taylor J; Xi Y; Howard JM; Ng YS; Wong D; Woldu SL; De Leon AD; Pedrosa I; Margulis V; Bagrodia A
Clin Genitourin Cancer; 2024 Feb; 22(1):33-37. PubMed ID: 37468341
[TBL] [Abstract][Full Text] [Related]
4. A Machine Learning Model to Predict the Histology of Retroperitoneal Lymph Node Dissection Specimens.
Nitta S; Kojima T; Gido M; Nakagawa S; Kakeya H; Kandori S; Kawahara T; Mathis BJ; Kawai K; Negoro H; Nishiyama H
Anticancer Res; 2024 May; 44(5):2151-2157. PubMed ID: 38677742
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
Taza F; Chovanec M; Snavely A; Hanna NH; Cary C; Masterson TA; Foster RS; Einhorn LH; Albany C; Adra N
J Clin Oncol; 2020 Apr; 38(12):1338-1345. PubMed ID: 32134699
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
Nestler T; Paffenholz P; Pfister D; Schoch J; Nini A; Hiester A; Albers P; Heidenreich A
J Urol; 2024 Mar; 211(3):426-435. PubMed ID: 38085711
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Antonelli L; Ardizzone D; Tachibana I; Adra N; Cary C; Hugar L; Sexton WJ; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Cazzaniga W; Nicol D; Gerdtsson A; Tandstad T; Fizazi K; Fankhauser CD;
J Clin Oncol; 2023 Dec; 41(34):5296-5305. PubMed ID: 37656935
[TBL] [Abstract][Full Text] [Related]
9. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.
Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG
J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
Macleod LC; Rajanahally S; Nayak JG; Parent BA; Ramos JD; Schade GR; Holt SK; Dash A; Gore JL; Lin DW
Urology; 2016 May; 91():70-6. PubMed ID: 26802801
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer.
D'Andrea V; Jason Qian Z; Yim K; Egan J; Magnani CJ; Feldman A; Salari K; Tewari A; Steele G; Mossanen M; Preston M; Chang SL; Clinton TN
Urol Oncol; 2023 Dec; 41(12):489.e1-489.e6. PubMed ID: 37980224
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.
Małkiewicz B; Świrkosz G; Lewandowski W; Demska K; Szczepaniak Z; Karwacki J; Krajewski W; Szydełko T
Curr Oncol Rep; 2024 Apr; 26(4):318-335. PubMed ID: 38430323
[TBL] [Abstract][Full Text] [Related]
14. Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study.
Rosenvilde JJ; Lauritsen J; Bandak M; Wagner T; Agerbæk M; Dysager L; Aagaard M; Daugaard G
Eur Urol Oncol; 2024 Jun; 7(3):589-596. PubMed ID: 38199869
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.
Yuan Y; Zhang D; Ning Y; Luo H; Qiu X; Tan Y; Li Y; Yang X
Front Oncol; 2023; 13():1257528. PubMed ID: 38169835
[TBL] [Abstract][Full Text] [Related]
16. Robot-assisted retroperitoneal lymph node dissection for post-chemotherapy residual mass in testicular cancer: Long-term experience from a tertiary care centre.
Vasudeo V; Khanna A; Pratihar SK; Jaipuria J; Chakraborty A; Rawal SK; Singh A
J Minim Access Surg; 2023; 19(2):288-295. PubMed ID: 36629220
[TBL] [Abstract][Full Text] [Related]
17. Post-chemotherapy modified template retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumours.
Zor M; Yilmaz S; Topuz B; Kaya E; Yalcin S; Coguplugil AE; Ince ME; Gurdal M
Aktuelle Urol; 2022 Aug; 53(4):325-330. PubMed ID: 34734394
[TBL] [Abstract][Full Text] [Related]
18. Critical elements of pediatric testicular germ cell tumors surgery.
Saltzman AF; Hensley P; Ross J; Woo L; Billmire D; Rescorla F; Puri D; Patel S; Pierorazio P; Bagrodia A; Cary C; Cost NG
Semin Pediatr Surg; 2023 Oct; 32(5):151343. PubMed ID: 38006835
[TBL] [Abstract][Full Text] [Related]
19. Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience.
Franzese D; Tufano A; Izzo A; Muscariello R; Grimaldi G; Quarto G; Castaldo L; Rossetti S; Pandolfo SD; Desicato S; Del Prete P; Ferro M; Pignata S; Perdonà S
Asian J Urol; 2023 Oct; 10(4):440-445. PubMed ID: 38024429
[TBL] [Abstract][Full Text] [Related]
20. Complex treatment of residual metastatic germ cell cancer: A single center experience.
Fazekas FE; Ujfaludi Z; Biró K; Páhi ZG; Buzogány I; Sükösd F; Pankotai T; Beöthe T
J Biotechnol; 2024 Apr; 389():61-67. PubMed ID: 38692356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
